About Sigma Aldrich
Sigma Aldrich is a Healthcare company based in St. Louis (United States) founded in 1951 by Alfred Bader, and was acquired by Merck in September 2014. It operates as a biochemical and organic chemicals are developed for scientific research applications. The company has 4,709 employees. Sigma Aldrich has completed 9 acquisitions, including Ace Animals, BioReliance and Cerilliant. Its chief executive is Udit Batra. Its website sigmaaldrich.com draws about 4.4 million monthly visits.
Company details
Sigma Aldrich was founded in 1951 in St. Louis, United States, within the chemicals sector. Biochemical and organic chemicals, along with related kits, are produced for applications in scientific research such as genomics, proteomics, biotechnology, and pharmaceutical development. Components are supplied for pharmaceutical, diagnostic, and manufacturing processes. Contract development and manufacturing services are provided for small and large molecules, leveraging bioprocess expertise.
- Headquarters St. Louis, United States
- Employees 4,709
- Founders Alfred Bader
- Stage Acquired
- SectorsHealthcare
- Website category Science and Education · Chemistry
- Website sigmaaldrich.com/US/en
- Social LinkedIn X
- Acquired by Merck (Sep 2014)
- Annual Revenue$13.53 K (USD)0as on Dec 31, 2014
- Net Profit$10.79 K (USD)109as on Dec 31, 2015
- InvestorsMerck
& 4 more
- Employee Count4,709
- Investments & AcquisitionsAce Animals
& 8 more
- Acquired byMerck
(Sep 2014)
Funding Insights of Sigma Aldrich
- Total Rounds 24
- First Round $850,000
(Jul 2008)
- Investors Count 4
Latest 10 of 24 funding rounds of Sigma Aldrich with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2024 | – | Grant | β | β | |
| Mar 2022 | $49,495 | Grant | β | β | |
| Feb 2021 | $764,866 | Grant | β | β | |
| Dec 2019 | $18,375 | Grant | β | β | |
| Sep 2017 | $11,260 | Grant | β | β | |
| Feb 2017 | – | Grant | β | β | |
| Jan 2017 | – | Grant | β | β | |
| Jul 2016 | $22,344 | Grant | β | β | |
| Mar 2016 | $22,330 | Grant | β | β | |
| Feb 2016 | $16,932 | Grant | β | β |
5 investors in total: 5 institutional.
Investors in Sigma Aldrich
Sigma Aldrich has secured backing from 5 investors, including institutional investors. Prominent investors backing the company include Merck, USAID and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
- | – | economie.gouv.fr | - | |
Global poverty and development are addressed through USAID initiatives. | 1961 | usaid.gov | - | |
Scientific and technical information is managed and disseminated by OSTI.GOV. | – | osti.gov | Oak Ridge, United States | |
Merck is engaged in science and technology solutions globally. | 1668 | merckgroup.com | Darmstadt, Germany |
Investor details for Sigma Aldrich
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Sigma Aldrich
101 people are tracked at Sigma Aldrich (27 in leadership, 74 in team); the tracked headcount is 4,709.
| Name | Role | Group |
|---|---|---|
Alfred Bader | Co-Founder | Leadership |
Udit Batra | CEO | Leadership |
Michal Daniely | Director, Research & Development | Leadership |
Jean-Charles Wirth | Head of Applied Solutions | Leadership |
David Hutchinson | General Counsel & Head of Legal Business Partners | Leadership |
Melissa Stoneman | Director, Global Marketing Communications | Leadership |
Karen Madden | Chief Technology Officer | Leadership |
Paul Ross | Director Of R&d And Technology Development | Leadership |
Matthias Heinzel | CEO | Leadership |
Shaf Yousaf | Chief Marketing Officer | Leadership |
Kasia Gralak McIpd | HR Business Partner | Leadership |
James Wareham | Vice President -global Sales, Inventory & Operational Planning | Leadership |
Bart Kerkman | Chief Information Officer | Leadership |
Tim M. Jaeger | EVP & Chief Strategy & Transformation Officer | Leadership |
Nelda Bonini | Head of Human Resources for Life Science | Leadership |
Gilles Fellous | Senior Director, IT Global Applications | Leadership |
Mark Robillard | VP - R&d | Leadership |
Steve Cecil | Director Strategic Business Development - Analytical | Leadership |
Cheryl Stipsits | Environmental, Health & Safety Director - St. Louis Operations | Leadership |
George Bleazard | Corporate Director - Ehs, Security, Transportation Compliance And Product Safety | Leadership |
81 more people are available in the full profile.
Complete people profiles for Sigma Aldrich
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sigma Aldrich
Sigma Aldrich has strategically engaged in corporate development activities, having acquired 9 companies. Notable acquisitions include Ace Animals, BioReliance and Cerilliant.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Developer of transfection reagents and electroporation products | mirusbio.com | Madison, United States | 1995 | May 2024 | $600M | |
Developer of acoustic particle trapping systems for applications in research and public health | fdsonics.com | Wilbraham, United States | 2010 | Oct 2019 | β’β’β’β’ | |
Energy generation and compliance services are provided by Fenix Power. | fenixpower.com.pe | – | 2014 | Dec 2015 | β’β’β’β’ | |
Biochemical reagents are manufactured for molecular biology and diagnostics. | resorg.com | Cleveland, United States | 1995 | Apr 2012 | β’β’β’β’ | |
Biosafety testing, biomanufacturing, and toxicology services are offered to clients. | bioreliance.com | Rockville, United States | 1947 | Jan 2012 | $350M | |
Certified reference standards are manufactured for analytical and forensic uses. | cerilliant.com | Round Rock, United States | 2009 | Dec 2010 | β’β’β’β’ | |
Research rodents are bred and supplied to the biomedical sector. | aceanimals.com | Berkshire County, United States | 1973 | Mar 2010 | β’β’β’β’ | |
Solutions and services to aid research organizations identify and procure the chemistry they need for drug discovery and agrochemical research. | chemnavigator.com | Milwaukee, United States | 1999 | Aug 2009 | β’β’β’β’ | |
CDMO focussed mainly on vaccines and gene therapy products | molecularmed.com | Carlsbad, United States | 1997 | May 2007 | β’β’β’β’ |
Complete acquisition details for Sigma Aldrich
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Sigma Aldrich
13 dated milestones of Sigma Aldrich across 73 years, from founding to its latest funding, stage changes and deals.
- Founded Sigma Aldrich is founded.
- Acquisition Acquires Molecular Medicine BioServices.
- Funding First funding round of $850K.
- Acquisition Acquires ChemNavigator.
- Acquisition Acquires Ace Animals.
- Acquisition Acquires Cerilliant.
- Acquisition Acquires BioReliance.
- Acquisition Acquires Research Organics.
- Exit Acquired by Merck.
- Acquisition Acquires Fenix ββPower.
- Acquisition Acquires FloDesign Sonics.
- Funding Latest funding round, Grant,.
- Acquisition Acquires Mirus Bio.
Web traffic of Sigma Aldrich
The website of Sigma Aldrich (sigmaaldrich.com) receives about 4.4M visits a month and ranks #15,208 among all websites worldwide, #789 in Chemistry.
- Monthly visits4.4M
▲ 8.4% vs previous month
- Unique visitors1.8M
per month
- Global rank#15,208
among all websites
- Category rank#789
Science and Education · Chemistry
- Bounce rate48%
- Pages per visit2.9
- Average visit2 min 46 sec
- DevicesDesktop 73% Β· Mobile 27%
Websites whose visitors overlap most with Sigma Aldrich. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| fishersci.com | 100% | 1.8M | #30,987 | View details | |
| tcichemicals.com | 66% | – | #60,674 | View details | |
| merckmillipore.com | 65% | 691.2K | #80,655 | View details | |
| abcam.com | 65% | 602.8K | #91,958 | View details | |
chemicalbook.com | chemicalbook.com | 61% | – | #35,490 | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 40 similar websites and full traffic analytics for Sigma Aldrich
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
10 companies that operate in the same segment as Sigma Aldrich (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | 1,111 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Sigma Aldrich
Complete news archive for Sigma Aldrich
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sigma Aldrich
Sigma Aldrich was founded in 1951 and raised its 1st funding round 57 years after it was founded.
Sigma Aldrich is headquartered in St. Louis, United States. It is registered at St. Louis, Missouri, United States.
Udit Batra is the current CEO of Sigma Aldrich.
Sigma Aldrich has 4,709 employees.
Annual revenue of Sigma Aldrich is $13.53K as on Dec 31, 2014.
Sigma Aldrich was founded in 1951 in St. Louis, United States, within the chemicals sector. Biochemical and organic chemicals, along with related kits, are produced for applications in scientific research such as genomics, proteomics, biotechnology, and pharmaceutical development. Components are supplied for pharmaceutical, diagnostic, and manufacturing processes. Contract development and manufacturing services are provided for small and large molecules, leveraging bioprocess expertise.
Sigma Aldrich has made 9 acquisitions, including Ace Animals, BioReliance, and Cerilliant.
Sigma Aldrich has 5 investors. Key investors include Merck, USAID, European Union, Ministry of Economy, Finance and Industrial and Digital Sovereignty, and OSTI.GOV.
Yes. Sigma Aldrich was acquired by Merck in September 2014.
The website of Sigma Aldrich receives about 4.4 million visits a month and ranks #15,208 among all websites worldwide.

